“Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study”, J of Skin, vol. 5, no. 6, p. s44, Nov. 2021, doi: 10.25251/skin.5.supp.44.